Read More Pharma Industry News Pfizer RSVpreF vaccine candidate gets another FDA breakthrough therapy status Pfizer said that PF-06928316 (RSVpreF), its respiratory syncytial virus (RSV) vaccine candidate, has been granted breakthrough therapy designation… bySrinathMarch 27, 2022
